Skip to main content
HRL
NYSE Manufacturing

Hormel Foods Reports Q1 FY26 Results: Sales Up 1.3%, EPS Up 6.5%, Announces Turkey Business Sale

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$25.305
Mkt Cap
$13.92B
52W Low
$21.03
52W High
$32.07
Market data snapshot near publication time

summarizeSummary

Hormel Foods reported a 1.3% increase in net sales and a 6.5% rise in diluted EPS for Q1 fiscal 2026, alongside a strategic divestiture and a planned sale of its turkey business, while also increasing its quarterly dividend.


check_boxKey Events

  • First Quarter Fiscal 2026 Financial Results

    Net sales increased 1.3% to $3.03 billion, with organic net sales up 1.6%. Diluted EPS rose 6.5% to $0.33, while adjusted diluted EPS decreased 2.9% to $0.34.

  • Strategic Divestiture and Planned Sale

    Completed the sale of a 51% equity interest in Justin's, LLC for $77.3 million, recognizing a $23.5 million pre-tax gain. Also entered into an agreement to sell the whole-bird turkey business, expected to close by Q2 fiscal 2026.

  • Strong Operating Cash Flow & Dividend Increase

    Cash flow from operations increased 13% to $349.2 million. The Board of Directors authorized a 1% increase in the quarterly dividend to $0.2925 per share.

  • Ongoing Restructuring Efforts

    Recognized $8.5 million in costs during the quarter related to a corporate restructuring plan aimed at reducing administrative expenses and improving efficiencies.


auto_awesomeAnalysis

This 10-Q provides the detailed financial results for Hormel Foods' first quarter of fiscal 2026, elaborating on the preliminary information likely released in an 8-K on the same day. While GAAP diluted EPS showed a healthy increase, the adjusted diluted EPS saw a slight decline, indicating the impact of one-time gains and ongoing restructuring costs. The company's strategic portfolio optimization is evident through the completed divestiture of Justin's, LLC and the announced sale of its whole-bird turkey business. Strong cash flow generation and a dividend increase underscore the company's financial health and commitment to shareholder returns, despite facing increased logistics costs. Investors should monitor the impact of ongoing restructuring efforts and the integration of portfolio changes on future profitability.

At the time of this filing, HRL was trading at $25.31 on NYSE in the Manufacturing sector, with a market capitalization of approximately $13.9B. The 52-week trading range was $21.03 to $32.07. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HRL - Latest Insights

HRL
Feb 26, 2026, 1:43 PM EST
Filing Type: 10-Q
Importance Score:
7
HRL
Feb 25, 2026, 5:39 PM EST
Filing Type: 8-K
Importance Score:
7